Intranasal peptide-induced tolerance and linked suppression: Consequences of complement deficiency

Immunology

Volumn 144, Issue 1, 2015, Pages 149-157

  Fossati Jimack, Liliane ^a   Ling, Guang Sheng ^a   Baudino, Lucie ^a   Szajna, Marta ^a   Manivannan, Kiruthika ^a   Zhao, Jade Chen ^a   Midgley, Robert ^a   Chai, Jian Guo ^a,b   Simpson, Elizabeth ^a   Botto, Marina ^a   Scott, Diane ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Complement; Dendritic cells; Regulatory T cells; Rodent; Tolerance

Indexed keywords

COMPLEMENT; HY ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PEPTIDE;

ANIMAL; CYTOLOGY; DENDRITIC CELL; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; KNOCKOUT MOUSE; MOUSE; REGULATORY T LYMPHOCYTE;

ADMINISTRATION, INTRANASAL; ANIMALS; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; FEMALE; H-Y ANTIGEN; IMMUNE TOLERANCE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES; T-LYMPHOCYTES, REGULATORY;

EID: 84918830010     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12358     Document Type: Article

References (53)

1. Carroll MC. The complement system in B cell regulation. Mol Immunol 2004; 41:141-6.
2. Kemper C, Atkinson JP. T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007; 7:9-18.
3. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22:431-56.
4. Taylor PR, Carugati A, Fadok VA et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192:359-66.
5. Prodeus AP, Goerg S, Shen LM, Pozdnyakova OO, Chu L, Alicot EM, Goodnow CC, Carroll MC. A critical role for complement in maintenance of self-tolerance. Immunity 1998; 9:721-31.
6. Ferry H, Potter PK, Crockford TL, Nijnik A, Ehrenstein MR, Walport MJ, Botto M, Cornall RJ. Increased positive selection of B1 cells and reduced B cell tolerance to intracellular antigens in c1q-deficient mice. J Immunol 2007; 178:2916-22.
7. Hammerberg C, Katiyar SK, Carroll MC, Cooper KD. Activated complement component 3 (C3) is required for ultraviolet induction of immunosuppression and antigenic tolerance. J Exp Med 1998; 187:1133-8.
8. Purwar R, Baumer W, Niebuhr M, Tschernig T, Kietzmann M, Werfel T. A protective role of complement component 3 in T cell-mediated skin inflammation. Exp Dermatol 2011; 20:709-14.
9. Pekkarinen PT, Vaali K, Jarva H et al. Impaired intestinal tolerance in the absence of a functional complement system. J Allergy Clin Immunol 2013; 131:1167-75.
10. Hsieh CC, Chou HS, Yang HR et al. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 2013; 121:1760-8.
11. Pepys MB. Role of complement in the induction of immunological responses. Transplant Rev (Orlando) 1976; 32:93-120.
12. Fearon DT, Carter RH. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 1995; 13:127-49.
13. Molina H, Holers VM, Li B et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996; 93:3357-61.
14. Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 2002; 8:373-8.
15. Suresh M, Molina H, Salvato MS, Mastellos D, Lambris JD, Sandor M. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J Immunol 2003; 170:788-94.
16. Lalli PN, Strainic MG, Yang M, Lin F, Medof ME, Heeger PS. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. Blood 2008; 112:1759-66.
17. + T cells. Immunity 2008; 28:425-35.
18. Lalli PN, Strainic MG, Lin F, Medof ME, Heeger PS. Decay accelerating factor can control T cell differentiation into IFN-γ-producing effector cells via regulating local C5a-induced IL-12 production. J Immunol 2007; 179:5793-802.
19. Peng Q, Li K, Anderson K, Farrar CA, Lu B, Smith RA, Sacks SH, Zhou W. Local production and activation of complement up-regulates the allostimulatory function of dendritic cells through C3a-C3aR interaction. Blood 2008; 111:2452-61.
20. Li K, Anderson KJ, Peng Q et al. Cyclic AMP plays a critical role in C3a-receptor-mediated regulation of dendritic cells in antigen uptake and T-cell stimulation. Blood 2008; 112:5084-94.
21. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8:582-7.
22. Baruah P, Simpson E, Dumitriu IE et al. Mice lacking C1q or C3 show accelerated rejection of minor H disparate skin grafts and resistance to induction of tolerance. Eur J Immunol 2010; 40:1758-67.
23. Bartel G, Brown K, Phillips R, Peng Q, Zhou W, Sacks SH, Wong W. Donor specific transplant tolerance is dependent on complement receptors. Transpl Int 2013; 26:99-108.
24. Derbyshire K, Addey C, Coe D et al. Molecular mechanisms of induction of antigen-specific allograft tolerance by intranasal peptide administration. J Immunol 2011; 186:5719-28.
25. Chai JG, James E, Dewchand H, Simpson E, Scott D. Transplantation tolerance induced by intranasal administration of HY peptides. Blood 2004; 103:3951-9.
26. Min WP, Zhou D, Ichim TE et al. Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol 2003; 170:1304-12.
27. Yates SF, Paterson AM, Nolan KF, Cobbold SP, Saunders NJ, Waldmann H, Fairchild PJ. Induction of regulatory T cells and dominant tolerance by dendritic cells incapable of full activation. J Immunol 2007; 179:967-76.
28. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19:56-9.
29. Wessels MR, Butko P, Ma M, Warren HB, Lage AL, Carroll MC. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc Natl Acad Sci USA 1995; 92:11490-4.
30. Wetsel RA, Fleischer DT, Haviland DL. Deficiency of the murine fifth complement component (C5). A 2-base pair gene deletion in a 5′-exon. J Biol Chem 1990; 265:2435-40.
31. Braun MY, Grandjean I, Feunou P, Duban L, Kiss R, Goldman M, Lantz O. Acute rejection in the absence of cognate recognition of allograft by T cells. J Immunol 2001; 166:4879-83.
32. Billingham RE, Medawar PB. The technique of free skin grafting in mammals. J Exp Biol 1951; 28:385-402.
33. Carlucci F, Fossati-Jimack L, Dumitriu IE et al. Identification and characterization of a lupus suppressor 129 locus on chromosome 3. J Immunol 2010; 184:6256-65.
34. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176:1693-702.
35. Yuan JS, Reed A, Chen F, Stewart CN Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006; 7:85.
36. Son M, Santiago-Schwarz F, Al-Abed Y, Diamond B. C1q limits dendritic cell differentiation and activation by engaging LAIR-1. Proc Natl Acad Sci USA 2012; 109:E3160-7.
37. Teh BK, Yeo JG, Chern LM, Lu J. C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation. Mol Immunol 2011; 48:1128-38.
38. Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells. J Exp Med 2013; 210:257-68.
39. Verginis P, McLaughlin KA, Wucherpfennig KW, von Boehmer H, Apostolou I. Induction of antigen-specific regulatory T cells in wild-type mice: visualization and targets of suppression. Proc Natl Acad Sci USA 2008; 105:3479-84.
40. + T regulatory cells. J Immunol 2007; 178:4022-6.
41. Cobbold SP, Adams E, Farquhar CA et al. Infectious tolerance via the consumption of essential amino acids and mTOR signaling. Proc Natl Acad Sci USA 2009; 106:12055-60.
42. Hosszu KK, Valentino A, Ji Y et al. Cell surface expression and function of the macromolecular c1 complex on the surface of human monocytes. Front Immunol 2012; 3:38.
43. + regulatory T cells. Nat Immunol 2013; 14:162-71.
44. Liszewski MK, Kolev M, Le Friec G et al. Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation. Immunity 2013; 39:1143-57.
45. + T cell activation. Eur J Immunol 2006; 36:2472-82.
46. Liang B, Workman C, Lee J et al. Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 2008; 180:5916-26.
47. + T cells triggers indoleamine 2, 3-dioxygenase activity in dendritic cells. J Immunol 2004; 172:4100-10.
48. Puccetti P, Grohmann U. IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation. Nat Rev Immunol 2007; 7:817-23.
49. Wei LH, Jacobs AT, Morris SM Jr, Ignarro LJ. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 2000; 279:C248-56.
50. Cobbold SP. The mTOR pathway and integrating immune regulation. Immunology 2013; 140:391-8.
51. Chappert P, Schwartz RH. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr Opin Immunol 2010; 22:552-9.
52. Bronte V, Zanovello P. Regulation of immune responses by l-arginine metabolism. Nat Rev Immunol 2005; 5:641-54.
53. Bobe P, Benihoud K, Grandjon D, Opolon P, Pritchard LL, Huchet R. Nitric oxide mediation of active immunosuppression associated with graft-versus-host reaction. Blood 1999; 94:1028-37.